Jiangsu SOPO Chemical Co Ltd

Jiangsu SOPO Chemical Co Ltd has a market capitalization of CNY 7.92 billion and a price-to-book ratio of 1.46, indicating a moderate premium to its book value. The company's liquidity position is characterized by a current ratio of 1.81, suggesting it can cover its short-term obligations with its current assets. However, the company's free cash flow is negative at CNY -727.61 million, and capital expenditures are substantial at CNY -1.27 billion, indicating significant reinvestment in operations. Profitability metrics show a return on equity (ROE) of 1.63% and a return on assets (ROA) of 1.19%, both below the typical thresholds for healthy returns in the commodity chemicals industry. The company's net income of CNY 88.38 million is modest relative to its revenue of CNY 5.86 billion, with a gross profit margin of 5.39% and an operating margin of 1.33%. These figures suggest the company is operating in a low-margin, highly competitive environment. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification beyond China. This concentration increases exposure to domestic economic conditions and regulatory changes. The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent fiscal year and no clear guidance for the next fiscal year. The company's risk profile includes a medium liquidity risk and a low dilution risk. The key liquidity flag is the negative net cash position after subtracting total debt, which could constrain operational flexibility. The company's debt-to-equity ratio of 0.14 indicates a conservative capital structure, but the negative free cash flow suggests potential future refinancing needs. Recent events include a significant capital expenditure outlay and a negative free cash flow, which may signal a strategic investment phase or operational challenges. No recent filings or transcripts have been disclosed that provide additional insight into the company's strategic direction or financial health.